The assessment of low‐dose carbon monoxide (CO) as a therapeutic in the clinic is unique
because of the diversity of data of the effects of low‐dose CO in humans. This chapter …

CARBON MONOXIDE IN DRUG DISCOVERY An insightful reference for the latest
physiological and therapeutic studies of carbon monoxide In Carbon Monoxide in Drug …

Carbon monoxide (CO) is an intrinsic signaling molecule with importance on par with that of
nitric oxide. During the past decade, pharmacologic studies have amply demonstrated the …

The discovery that carbon monoxide (CO)—a highly publicized toxic gas molecule—can
have powerful benefits and curative effects not only changed how we view CO, but has, with …

The use of Carbon Monoxide (CO) as a therapeutic agent has already been tested in human
clinical trials. Pre-clinically, CO gas administration proved beneficial in animal models of …

Carbon monoxide (CO) is a known endogenous signaling molecule with potential
therapeutic indications in treating inflammation, cancer, neuroprotection, and sickle cell …

Carbon monoxide (CO) is one of the most common causes of inhalation poisoning
worldwide. However, it is also well known that CO is produced endogenously in the heme …

Carbon monoxide is a molecule with notoriety in modern culture and extensive
documentation regarding its toxic physiological effects, long predating its formal discovery in …

Carbon monoxide (CO) is attracting increasing attention because of its role as a
gasotransmitter with cytoprotective and homeostatic properties. Carbon monoxide releasing …

Carbon monoxide (CO) has been firmly established as an endogenous signaling molecule
with a variety of pathophysiological and pharmacological functions, including …